Dali
Mandar V. Dali, New Brunswick, NJ US
Patent application number | Description | Published |
---|---|---|
20080234366 | PHARMACEUTICAL FORMULATION CONTAINING AN SGLT2 INHIBITOR - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 09-25-2008 |
20110064801 | Pharmaceutical Formulations Containing an SGLT2 Inhibitor - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 03-17-2011 |
20120263786 | Pharmaceutical Formulations Containing an SGLT2 Inhibitor - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 10-18-2012 |
Mandar V. Dali, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20090186857 | Combretastatin A-4 Phosphate Prodrug Mono- and Di- Organic Amine Salts, Mono- and Di- Amino Acid Salts, and Mono- and Di- Amino Acid Ester Salts - Provided herein are novel and useful combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologically tolerable products as a result of the regeneration of combretastatin A-4. | 07-23-2009 |
20130129819 | Pharmaceutical Formulations Containing An SGLT2 Inhibitor - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 05-23-2013 |
20140243262 | PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR - Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate | 08-28-2014 |
Manisha M. Dali, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20090186857 | Combretastatin A-4 Phosphate Prodrug Mono- and Di- Organic Amine Salts, Mono- and Di- Amino Acid Salts, and Mono- and Di- Amino Acid Ester Salts - Provided herein are novel and useful combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologically tolerable products as a result of the regeneration of combretastatin A-4. | 07-23-2009 |
20100166774 | Stable Protein Formulations - The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction. | 07-01-2010 |
20120035177 | TABLET FORMULATION FOR P38 INHIBITOR AND METHOD - A tablet formulation is provided which includes a medicament which is a pharmaceutically acceptable salt of a p38 inhibitor, such as the p38 HCl salt of the structure Formula (I) and which has good physical stability when stored at up to 25 C./60% RH in closed containers with desiccant. The tablet formulation will contain crospovidone as a tablet disintegrant, which, unlike croscarmellose sodium, will not cause disproportionation of the HCl salt to the free base of P38 inhibitor and thus will have acceptable dissolution properties even after storage at room temperature. | 02-09-2012 |
Manish D. Dali, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20130216541 | STABLE SUBCUTANEOUS PROTEIN FORMULATIONS AND USES THEREOF - The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction. | 08-22-2013 |
Sun Dali, Beijing CN
Patent application number | Description | Published |
---|---|---|
20150365514 | METHOD FOR REAL TIME DISPLAYING INFORMATION AND MOBILE COMMUNICATION TERMINAL - The embodiment of the present invention discloses a method for real-time displaying information and a mobile communication terminal. The method includes: searching multiple kinds of attribute information of a current communication object in the mobile communication terminal upon communication of the mobile communication terminal; determining at least one kind of attribute information of the multiple kinds of attribute information changed in a server; acquiring the changed attribute information from the server, so as to update the multiple kinds of attribute information; and displaying the updated multiple kinds of attribute information on a communication interface of the mobile communication terminal according to a preset display format. The embodiment of the present invention may reduce the user's operations, make the display of the information more consistent and facilitate browsing information for a user. | 12-17-2015 |
Vishal Dali, Richardson, TX US
Patent application number | Description | Published |
---|---|---|
20110060693 | Vending Machine for Large Product Containers - The present invention provides machines, methods and apparatus for automatically vending, damping, delivering and returning large heavy product containers such as 5-gallon water bottles. In some embodiments, damping methods and apparatus are provided to gently transfer large heavy product containers from one level to another inside a vending machine. In some embodiments, methods and apparatus including adjustable support rails are provided for handling different sized large heavy product containers inside a vending machine. In some embodiments, delivery methods and apparatus are provided for use with large heavy product containers. In some embodiments, methods and apparatus for returning large product containers are provided. Some or all of these features may be provided in a single vending machine, or in multiple machines, and multiple features or machines may be controlled by a single computer processor. | 03-10-2011 |
20110071772 | Methods for Monitoring and Managing Delivery of Syrup in Bag-In-Box Systems - The present invention includes systems, methods and apparatus for detecting whether an acceptable mixture of fluid and water has been delivered by a vending machine. Embodiments of the invention utilize one or more second flow meters located downstream of a mix manifold. The additional flow meter allows the controller of the delivery system or vending machine to monitor and compare the volume of water to the volume of the final mix in order to determine whether an appropriate volume of syrup has or has not been mixed in the dispensed beverage. | 03-24-2011 |